WHO ICTRP trial
Is treatment with the painkiller paracetamol safe in patients with spinal…
EUCTR2018-002295-40-DK · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-002295-40-DK |
|---|---|
| Public title | Is treatment with the painkiller paracetamol safe in patients with spinal muscular atrophy and cerebral palsy? |
| Scientific title | Pharmacokinetics and safety of treatment with paracetamol in children and adults with spinal muscular atrophy and cerebral palsy - Paracetamol study in patients with low muscle mass |
| Primary sponsor | Copenhagen Neuromuscular Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Spinal muscular atrophy type II (SMA II) Cerebral palsy (CP);Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Pharmaceutical Form: Oral suspension INN or Proposed INN: Paracetamol Other descriptive name: PARACETAMOL Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 24- |
| Registration date | Nov 7, 2018 |
| Target size | 24 |
| Secondary IDs | 08-06-2018-paracet |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: